FDA Accepts NDA for Zoliflodacin, Potentially First Gonorrhea Antibiotic in Decades

FDA Accepts NDA for Zoliflodacin, Potentially First Gonorrhea Antibiotic in Decades

The FDA has accepted a New Drug Application for zoliflodacin, a first-in-class oral antibiotic for treating uncomplicated gonorrhea, offering a potential new option amid rising antibiotic resistance.

Zoliflodacin wins FDA nod for treatment of gonorrhea

The FDA has approved zoliflodacin, a single-dose, spiropyrimidinetrione oral antibiotic for the treatment of uncomplicated gonorrhea in adults and pediatric patients 12 years and older, Innoviva announced on Tuesday. The oral antibiotic inhibits type II topoisomerase, a bacterial enzyme crucial to bacterial function and reproduction.  What laid the groundwork for FDA’s zoliflodacin approval The FDA… The post Zoliflodacin wins FDA nod for treatme…